ID | Gender | Age (years) | Disease duration (years) | Current medication | HAQ | Patient global | Foot global | Accessed foot care |
---|---|---|---|---|---|---|---|---|
1 | Male | 61 | 3 | Biologics, DMARDs, GC | 2.875 | 6 | 6 | Yes |
2 | Female | 62 | 2 | DMARDs, GC | 0.375 | 2 | 3 | No |
3 | Male | 39 | 2 | DMARDs, GC, NSAIDs | 0 | 1 | 1 | No |
4 | Male | 55 | 27 | Biologics, DMARDs, NSAIDs | 2.75 | 8 | 9 | Yes |
5 | Female | 61 | 23 | DMARDS, GC, NSAIDs | 2.75 | 7 | 7 | Yes |
6 | Male | 54 | 2 | Biologics, DMARDS, GC, NSAIDs | 2 | 8 | 9 | No |
7 | Female | 71 | 11 | Biologics | 0.375 | 7 | 1 | No |
8 | Male | 72 | 20 | DMARDs, NSAIDs | 1.87 | 9 | 5 | Yes |
9 | Female | 46 | 24 | Biologics, DMARDs, NSAIDs | 2.375 | 6 | 8 | Yes |
10 | Female | 29 | 5 | GC | 0 | 0 | 0 | No |
11 | Female | 55 | 7 | DMARDs, NSAIDs | 1.87 | 5 | 7 | Yes |
12 | Female | 69 | 18 | DMARDs | 1.75 | 7 | 8 | Yes |
Mean | Â | 56.2 | 12.0 | Â | 1.56 | 5.5 | 5.3 | Â |
Range |  | (29–72) | (2–27) |  | (0–2.875) | (0–9) | (0–9) |  |